$10.68
0.030.28%
At close: -
$10.68
0.000.00%
After Hours: 4:00 PM EDT
Bioventus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bioventus using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $0.06 | $0.03 | 100.0 % |
Q2 | 2024-08-06 | $0.19 | $0.07 | 171.4 % |
Q1 | 2024-05-07 | $0.07 | $-0.07 | 200.0 % |
Q4 | 2024-03-12 | $0.07 | $0.02 | 250.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $138.96M | $133.23M | 4.30 % |
Q2 | 2024-08-06 | $151.22M | $137.59M | 9.90 % |
Q1 | 2024-05-07 | $129.46M | $118.38M | 9.36 % |
Q4 | 2024-03-12 | $135.42M | $123.96M | 9.25 % |
Bioventus (BVS) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $0.06, which beat the estimate of $0.03.
The Actual Revenue was $139M, which beat the estimate of $133.2M.
Browse earnings estimates, EPS, and revenue on all stocks.